About: Ivo Mueller

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Ivo Mueller Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

researcher ORCID ID = 0000-0001-6554-6889

Attributes	Values
rdf:type	Item
description	forskare (sv) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh) onderzoeker (nl) researcher ORCID ID = 0000-0001-6554-6889 (en)
rdfs:label	Ivo Mueller (en) Ivo Mueller (es) Ivo Mueller (nl) Ivo Mueller (ast)
skos:prefLabel	Ivo Mueller (en) Ivo Mueller (es) Ivo Mueller (nl) Ivo Mueller (ast)
name	Ivo Mueller (en) Ivo Mueller (es) Ivo Mueller (nl) Ivo Mueller (ast)
Scopus author ID	wds:Q60043791-83B9ECB2-6BB9-47D4-A960-E063234D5D81
Scopus author ID	7006910183
given name	wds:Q60043791-E23419F1-F7AE-4235-97E1-AFE54DD5AE43
given name	Ivo
instance of	wds:Q60043791-5AF3CB54-DC19-4EF3-8124-825E07EDF52A
instance of	Homo sapiens
occupation	wds:Q60043791-E1A4B42B-D9D2-4D6F-8679-978A9C3D94D8
employer	wds:Q60043791-B735FD70-FA0F-4E1D-9C7B-9871E6BF2542
sex or gender	wds:Q60043791-4fb7c722-4ec0-0cbc-f209-e493475015dc
VIAF ID	wds:Q60043791-5104c9b3-16b5-4f11-a04c-6052ef0f2f3f
IdRef ID	wds:Q60043791-1F142DDE-7EE3-4332-9BDC-496C924F23B2
family name	wds:Q60043791-DE356458-4FF0-4407-BAEF-49BD49BA6146
VIAF ID	http://viaf.org/viaf/141158125185214932347
IdRef ID	http://www.idref.fr/241942551/id
occupation	researcher
employer	WEHI
sex or gender	male
VIAF ID	141158125185214932347
IdRef ID	241942551
family name	Mueller
ORCID iD	wds:Q60043791-960882C5-0632-4E58-8C23-88C3A4D388C2
ORCID iD	https://orcid.org/0000-0001-6554-6889
ORCID iD	0000-0001-6554-6889
ResearcherID	wds:Q60043791-DD1AA505-76CD-4014-AFB1-1D18F79C6A4E
ResearcherID	C-7251-2013
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q60043791
is author of	Characterization of treatment failure in efficacy trials of drugs against Plasmodium vivax by genotyping neutral and drug resistance-associated markers Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing The Plasmodium falciparum erythrocyte invasion ligand Pfrh4 as a target of functional and protective human antibodies against malaria. Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development Association between naturally acquired antibodies to erythrocyte-binding antigens of Plasmodium falciparum and protection from malaria and high-density parasitemia. Evidence that the erythrocyte invasion ligand PfRh2 is a target of protective immunity against Plasmodium falciparum malaria. Cost-effectiveness of artemisinin combination therapy for uncomplicated malaria in children: data from Papua New Guinea Effectiveness of artemether/lumefantrine for the treatment of uncomplicated Plasmodium vivax and P. falciparum malaria in young children in Papua New Guinea Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1-5 years of age. Reported reasons for not using a mosquito net when one is available: a review of the published literature Malaria--a major health problem within an oil palm plantation around Popondetta, Papua New Guinea Implications of Plasmodium vivax Biology for Control, Elimination, and Research Genomic analysis of local variation and recent evolution in Plasmodium vivax Malaria Epidemiology and Control Within the International Centers of Excellence for Malaria Research Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax Prevalence of malaria across Papua New Guinea after initial roll-out of insecticide-treated mosquito nets High levels of genetic diversity of Plasmodium falciparum populations in Papua New Guinea despite variable infection prevalence Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite Transfer of chloroquine and desethylchloroquine across the placenta and into milk in Melanesian mothers Genome-wide and fine-resolution association analysis of malaria in West Africa Plasmodium vivax Diversity and Population Structure across Four Continents Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean children How much remains undetected? Probability of molecular detection of human Plasmodia in the field Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea A Large Plasmodium vivax Reservoir and Little Population Structure in the South Pacific A high force of plasmodium vivax blood-stage infection drives the rapid acquisition of immunity in papua new guinean children Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1). Plasmodium vivax populations are more genetically diverse and less structured than sympatric Plasmodium falciparum populations Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes Plasmodium malariae and Plasmodium ovale--the "bashful" malaria parasites Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model A multiplex ligase detection reaction-fluorescent microsphere assay for simultaneous detection of single nucleotide polymorphisms associated with Plasmodium falciparum drug resistance Features and prognosis of severe malaria caused by Plasmodium falciparum, Plasmodium vivax and mixed Plasmodium species in Papua New Guinean children Reference intervals for common laboratory tests in Melanesian children Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria Treatment with coartem (artemether-lumefantrine) in Papua New Guinea Microsatellite polymorphism within pfcrt provides evidence of continuing evolution of chloroquine-resistant alleles in Papua New Guinea Molecular evidence for the localization of Plasmodium falciparum immature gametocytes in bone marrow Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans Predicting antidisease immunity using proteome arrays and sera from children naturally exposed to malaria An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection Acquisition and Longevity of Antibodies to Plasmodium vivax Preerythrocytic Antigens in Western Thailand Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness Acquisition of Functional Antibodies That Block the Binding of Erythrocyte-Binding Antigen 175 and Protection Against Plasmodium falciparum Malaria in Children A single point in protein trafficking by Plasmodium falciparum determines the expression of major antigens on the surface of infected erythrocytes targeted by human antibodies Natural acquisition of immunity to Plasmodium vivax: epidemiological observations and potential targets Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study Comparison of three methods for detection of gametocytes in Melanesian children treated for uncomplicated malaria

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software